CpG-free neo

CpG-free neo confers resistance to Kanamycin in E. coli and G418 in mammalian cells. This DNA sequence is based on the Tn5 aph2 gene and encodes aminoglycoside 3‘-phosphotransferase, APH 3‘ II. The gene was modified by optimizing the codon usage and deleting the CpG motifs without changing the amino acid sequence of the wild type protein.

The synthetic neo gene is provided in the bacterial plasmid pMOD2 which is selectable with Ampicillin. To facilitate the excision and subcloning of the synthetic neo gene into another vector, this gene is flanked by a unique restriction site at the 5’ and 3’ end.


Gene: CpG-free neo
Description: Synthetic Neomycin resistance gene
Backbone: pMOD2
Selection: Ampicillin

74 CpG in the native gene


• 20 µg of lyophilized pMOD2-Neo plasmid DNA
• 4 pouches of E. coli Fast-Media® Amp (2 LB and 2 Agar)



Description pMOD2 bearing bacteria Synthetic neo Gene
Cat. Codepmod2-neo
Unit Size20 µg
Price For price or distributor address,
please select your country
Disclaimer: Our products are provided for research purpose only. Commercial applications may require licensing from third parties.
Note that the sequence of available ORFs provided by InvivoGen can differ from a given reference Genbank record due to genetic variations and/or alternative splicing. Customers should verify that the version of a gene sold by InvivoGen is suitable for the customer needs.
Copyrights © 2011-2016 InvivoGen. All Rights Reserved. Reproduction of any materials from this site is strictly forbidden without permission for commercial use. Nonprofit use for non-commercial research and educational purposes is permitted, citation should include the URL "www.invivogen.com".